Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemoradiotherapy in gallbladder cancer.

Xabier de Aretxabala1, Ivan Roa, Marcela Berrios

  • 1Department of Surgery, Clinica Alemana, Santiago, Chile. xdearetxabala@alemana.cl

Journal of Surgical Oncology
|May 26, 2006
PubMed
Summary

Gallbladder cancer (GC) treatment lacks robust evidence. Gemcitabine-based therapies show modest response rates, but further research is crucial for effective adjuvant, neoadjuvant, and palliative strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Framework for evaluating in vitro vasculogenic mimicry using structural and metabolic parameters.

Cell reports methods·2026
Same author

A Pilot Study of Plasma Cell-Free DNA Fragmentomics in Gallbladder Cancer.

JHEP reports : innovation in hepatology·2026
Same author

Neuroendocrine Tumors of the Gallbladder: A Multicenter Case Series and Systematic Literature Review Indicating Predominantly Non-Aggressive Tumor Behavior and a Common Association with Cholesterol Polyps and Cholesterolosis.

Endocrine pathology·2026
Same author

The Chile BiLS case-control study of gallbladder cancer.

Archives of public health = Archives belges de sante publique·2026
Same author

ThyroidPrint: Thyroid Genetic Classifier Long-Term Follow-Up of Benign Called Lesions.

Clinical endocrinology·2026
Same author

Neuroprotective and antioxidant effects of fermented spent coffee ground fractions against Alzheimer's-related oxysterol 27-hydroxycholesterol in SH-SY5Y neuronal cells.

Food chemistry·2026

Area of Science:

  • Oncology
  • Gastrointestinal Oncology

Background:

  • Gallbladder cancer (GC) is a rare malignancy with a poor prognosis.
  • Limited patient numbers hinder clinical trial design for adjuvant, neoadjuvant, and palliative therapies.
  • Historically, 5-fluorouracil (5-FU)-based treatments yielded poor outcomes.

Purpose of the Study:

  • To review current treatment strategies for gallbladder cancer.
  • To highlight the need for evidence-based therapeutic approaches.
  • To evaluate the potential of novel drug combinations and chemoradiation.

Main Methods:

  • Review of existing clinical trials and treatment guidelines.
  • Analysis of response rates for different chemotherapeutic agents.
  • Assessment of the rationale for combining chemotherapy with radiation.

Related Experiment Videos

Main Results:

  • Gemcitabine-based regimens achieve response rates around 30%.
  • Concurrent use of Cisplatin and Capecitabine with gemcitabine and/or radiation is being explored.
  • Chemoradiation is a logical consideration due to the disease's recurrence pattern.

Conclusions:

  • Current gallbladder cancer treatment recommendations often extrapolate from other biliary tract cancers (BTC) and pancreas cancer data.
  • There is a significant lack of specific evidence for gallbladder cancer therapies.
  • Further dedicated research is essential to optimize treatment for gallbladder cancer.